PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.44 - 1.45
1.18 - 2.36
71.0K / 1.73M (Avg.)
-18.12 | -0.08
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
37.14%
Positive revenue growth while 1113.HK is negative. John Neff might see a notable competitive edge here.
34.50%
Positive gross profit growth while 1113.HK is negative. John Neff would see a clear operational edge over the competitor.
-29.21%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
8.25%
Positive operating income growth while 1113.HK is negative. John Neff might view this as a competitive edge in operations.
-28.65%
Negative net income growth while 1113.HK stands at 63.39%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-30.77%
Negative EPS growth while 1113.HK is at 63.17%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-30.77%
Negative diluted EPS growth while 1113.HK is at 63.17%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
0.24%
Share count expansion well above 1113.HK's 0.02%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
0.24%
Diluted share count expanding well above 1113.HK's 0.02%. Michael Burry would fear significant dilution to existing owners' stakes.
No Data
No Data available this quarter, please select a different quarter.
-2.56%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-1.94%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
-3.78%
Negative 10Y revenue/share CAGR while 1113.HK stands at 82.62%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
11301.73%
5Y revenue/share CAGR above 1.5x 1113.HK's 106.04%. David Dodd would look for consistent product or market expansions fueling outperformance.
543.21%
Positive 3Y CAGR while 1113.HK is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
-154.74%
Negative 10Y OCF/share CAGR while 1113.HK stands at 716.07%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
29.96%
Below 50% of 1113.HK's 456.08%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
-90.57%
Negative 3Y OCF/share CAGR while 1113.HK stands at 1133.46%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
-552.26%
Negative 10Y net income/share CAGR while 1113.HK is at 202.86%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-1545.34%
Negative 5Y net income/share CAGR while 1113.HK is 258.27%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
40.64%
Below 50% of 1113.HK's 275.02%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
No Data
No Data available this quarter, please select a different quarter.
-13.62%
Negative 5Y equity/share growth while 1113.HK is at 1417.07%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
-40.12%
Negative 3Y equity/share growth while 1113.HK is at 30.87%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
-100.00%
Cut dividends over 10 years while 1113.HK stands at 0.00%. Joel Greenblatt suspects a weaker ability to return capital vs. the competitor.
-100.00%
Negative 5Y dividend/share CAGR while 1113.HK stands at 0.00%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
20.44%
Inventory growth well above 1113.HK's 1.37%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
-4.34%
Negative asset growth while 1113.HK invests at 1.17%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-8.62%
We have a declining book value while 1113.HK shows 6.65%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
24.79%
We have some new debt while 1113.HK reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
No Data
No Data available this quarter, please select a different quarter.
-57.76%
We cut SG&A while 1113.HK invests at 1.32%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.